Maggiore Christopher D. — SEC Form 4 filings
SEC reporting owner CIK 1436075. 9 Form 4 filings on record with FilingPulse; latest filed 2026-01-27.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-06-06 to 2026-01-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 62,628 shares, $607,499 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 20 shares, $325 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 23,682 shares @ $12.01 ($284,421) in Zivo Bioscience, Inc., filed 2025-10-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Zivo Bioscience, Inc. (ZIVO) | Director, 10% owner | 9 | 5 legs · 62,628 sh · $607,499 | 1 leg · 20 sh · $325 | 13 |
Form 4 filings — Maggiore Christopher D.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-27 | 4 | Zivo Bioscience, Inc. (ZIVO) | Purchase (P): 1,766 @ $8.49 | EDGAR |
| 2025-10-09 | 4 | Zivo Bioscience, Inc. (ZIVO) | Purchase (P): 23,682 @ $12.01 | EDGAR |
| 2025-10-06 | 4 | Zivo Bioscience, Inc. (ZIVO) | Grant/award (A): 1,075 (derivative) @ $10.20 | EDGAR |
| 2025-04-09 | 4 | Zivo Bioscience, Inc. (ZIVO) | Sale (S): 20 @ $16.25 | EDGAR |
| 2025-01-03 | 4 | Zivo Bioscience, Inc. (ZIVO) | Grant/award (A): 1,300 @ $0 · Grant/award (A): 7,277 @ $0 | EDGAR |
| 2024-08-23 | 4 | Zivo Bioscience, Inc. (ZIVO) | Purchase (P): 31,336 @ $8.34 · Purchase (P): 3,133 (derivative) @ $8.34 | EDGAR |
| 2024-07-30 | 4 | Zivo Bioscience, Inc. (ZIVO) | Purchase (P): 2,080 @ $8.05 · Purchase (P): 208 (derivative) @ $8.05 | EDGAR |
| 2024-06-13 | 4 | Zivo Bioscience, Inc. (ZIVO) | Grant/award (A): 6,273 @ $0 · Purchase (P): 3,764 @ $7.97 | EDGAR |
| 2024-06-06 | 4 | Zivo Bioscience, Inc. (ZIVO) | Grant/award (A): 36,630 · Grant/award (A): 81,544 @ $7.96 · Disposition to issuer (D): 1,902 (derivative) · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 2,632 (derivative) · Disposition to issuer (D): 707 (derivative) · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1436075 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →